|
|
40
|
|
|
1131FD
|
|
|
ROSUVASTATIN 5MG TAB (MCP/AHI)
|
|
|
ROSUVASTATIN
|
|
|
ROSUVASTATIN
|
|
|
3X10
|
|
|
A
|
|
|
2.01
|
|
|
0.07
|
|
|
5MG
|
|
|
TABLET
|
|
|
30
|
|
|
TAB
|
|
|
MCP
|
|
|
MACLEODS PHARMACEUTICALS LTD
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
1TOD
|
|
|
1
|
|
|
No
|
|
|
240608
|
|
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
|
Oral
|
|
|
6
|
|
|
CARDIOVASCULAR DRUGS
|
|
|
|